Bollard Group’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,215
| Closed | -$19K | – | 402 |
|
|
2022
Q1 | $19K | Hold |
2,215
| – | – | ﹤0.01% | 387 |
|
|
2021
Q4 | $35K | Hold |
2,215
| – | – | ﹤0.01% | 371 |
|
|
2021
Q3 | $41K | Hold |
2,215
| – | – | ﹤0.01% | 361 |
|
|
2021
Q2 | $31K | Hold |
2,215
| – | – | ﹤0.01% | 375 |
|
|
2021
Q1 | $33K | Hold |
2,215
| – | – | ﹤0.01% | 372 |
|
|
2020
Q4 | $43K | Hold |
2,215
| – | – | ﹤0.01% | 350 |
|
|
2020
Q3 | $25K | Hold |
2,215
| – | – | ﹤0.01% | 372 |
|
|
2020
Q2 | $30K | Buy |
+2,215
| New | +$30K | ﹤0.01% | 389 |
|